CRIS Current Research Information System

ZANELLO, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.846
EU - Europa 1.672
AS - Asia 911
AF - Africa 142
SA - Sud America 4
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.579
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.838
GB - Regno Unito 490
VN - Vietnam 308
CN - Cina 304
SE - Svezia 253
IT - Italia 222
DE - Germania 218
SG - Singapore 159
UA - Ucraina 156
IN - India 93
FR - Francia 82
IE - Irlanda 79
RU - Federazione Russa 55
TG - Togo 46
CI - Costa d'Avorio 40
EE - Estonia 36
ZA - Sudafrica 30
BG - Bulgaria 23
CH - Svizzera 20
JO - Giordania 17
IR - Iran 13
SC - Seychelles 12
NG - Nigeria 11
BE - Belgio 9
FI - Finlandia 9
CA - Canada 7
ES - Italia 7
JP - Giappone 7
UZ - Uzbekistan 4
AU - Australia 3
CZ - Repubblica Ceca 3
ET - Etiopia 2
HR - Croazia 2
IL - Israele 2
LB - Libano 2
PL - Polonia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AT - Austria 1
BD - Bangladesh 1
BR - Brasile 1
CL - Cile 1
DZ - Algeria 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
HU - Ungheria 1
NL - Olanda 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
Totale 5.579
Salva come PNG Salva come JPEG
Città #
Southend 442
Fairfield 413
Chandler 338
Ashburn 235
Dong Ket 202
Woodbridge 179
Seattle 167
Wilmington 163
Houston 158
Singapore 134
Cambridge 132
Princeton 108
Jacksonville 105
Ann Arbor 97
Dublin 79
Nanjing 54
Westminster 47
Lomé 46
Padova 43
Abidjan 40
Bologna 40
Berlin 34
San Diego 31
Dearborn 29
Santa Clara 27
Jinan 25
Saint Petersburg 24
Sofia 23
New York 21
Turin 19
Des Moines 18
Amman 17
Bern 17
Florence 17
Los Angeles 17
Milan 17
Mülheim 16
Shenyang 15
Nanchang 14
Mahé 12
Hebei 11
Mountain View 11
Redwood City 11
Abeokuta 10
Beijing 9
Boardman 9
Brussels 9
Guangzhou 9
Helsinki 9
Olalla 9
Tianjin 9
Changsha 8
Monmouth Junction 7
Shanghai 7
Tokyo 7
Verona 7
Falls Church 6
Jiaxing 6
London 6
Ningbo 6
Redmond 6
Zhengzhou 6
Haikou 5
Leawood 5
Madrid 5
Norwalk 5
Qingdao 5
Bühl 4
Edinburgh 4
Frankfurt am Main 4
Fremont 4
Fuzhou 4
Lanzhou 4
Medford 4
Rome 4
Taizhou 4
Zanjan 4
Ardabil 3
Catania 3
Hangzhou 3
Hefei 3
Kunming 3
Paris 3
Plauen 3
San Venanzo 3
Toronto 3
Addis Ababa 2
Augusta 2
Baoding 2
Casalecchio di Reno 2
Chengdu 2
Giugliano in Campania 2
Harbin 2
Hyderabad 2
Islington 2
Laterza 2
Lausanne 2
Ludwigshafen 2
Monzuno 2
New Delhi 2
Totale 3.913
Salva come PNG Salva come JPEG
Nome #
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. 184
A new liver transplant priority for patients with hepatocellular carcinoma. 182
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 175
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 168
MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis b-and c-related-hepatocellularcarcinoma 160
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 151
Anatomic variations of intrahepatic bile ducts in a European series and meta-analysis of the literature. 142
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. 140
Appraisal of disease-specific benefits of minimally invasiveness in surgery of breast cancer liver metastases 140
Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 137
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 137
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 136
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. 135
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. 135
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation. 132
Using Elderly Donors in Liver Transplantation. 129
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 127
Matricellular proteins and survival in patients with pancreatic cancer: A systematic review 127
Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review 123
Incidence and management of abdominal closure-related complications in adult intestinal transplantation. 121
Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases. 119
Comparison between observed survival after resection of transplantable hepatocellular carcinoma and predicted survival after listing through a Markov model simulation. 117
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. 116
Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna. 113
Psychological Adaptation and Quality of Life of Adult Intestinal Transplant Recipients: University of Bologna Experience 109
Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. 108
Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab. 108
The role of liver resections for metastases from lung carcinoma. 107
Liver transplantations with donors aged 60 years and above: the low liver damage strategy 106
Ruolo della linfadenectomia in corso di epatectomia per metastasi colorettali. 99
Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables. 98
The role of liver resections for metastases from lung carcinoma 97
Improved diagnostic imaging and interventional therapies prolong survival after resection for hepatocellular carcinoma in cirrhosis: the university of bologna experience over 10 years. 95
Prognostic criteria for postoperative mortality in 170 patients undergoing major right hepatectomy 93
Hepatitis B virus and hepatitis C virus infections and risk of pancreatic ductal adenocarcinoma 93
Sirolimus in liver transplant recipients: a large single-center experience. 91
The role of liver surgery in the treatment of non-colorectal non-neuroendocrine metastases (NCRNNE). Analysis of 134 resected patients. 89
Impact of very advanced donor age on hepatic artery thrombosis after liver transplantation. 89
Prophylaxis for venous thromboembolism after resection of hepatocellular carcinoma on cirrhosis: is it necessary? 89
Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease. 88
Prospective down-staging protocol for HCC not meeting the Milan criteria 88
Nested stromal-epithelial tumor (NSET) of the liver: A case report of an extremely rare tumor. 83
Strategies to Increase the Resectability of Patients with Colorectal Liver Metastases: A Multi-center Case-Match Analysis of ALPPS and Conventional Two-Stage Hepatectomy 82
The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer 78
Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience 72
Hepatocellular carcinoma surgical and oncological trends in a national multicentric population: the HERCOLES experience 67
Hepatectomy for Metabolic Associated Fatty Liver Disease (MAFLD) related HCC: Propensity case-matched analysis with viral- and alcohol-related HCC 66
Use of vascular clamping in hepatic surgery: lessons learned from 1260 liver resections. 64
The Effect of a Liver Transplant Program on the Outcomes of Resectable Hepatocellular Carcinoma: A Nationwide Multicenter Analysis 51
The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study 35
Evolution of minimally invasive techniques and surgical outcomes of ALPPS in Italy: a comprehensive trend analysis over 10 years from a national prospective registry 28
Benchmarking postoperative outcomes after open liver surgery for cirrhotic patients with hepatocellular carcinoma in a national cohort 22
Correction: Evolution of minimally invasive techniques and surgical outcomes of ALPPS in Italy: a comprehensive trend analysis over 10 years from a national prospective registry (Surgical Endoscopy, (2023), 10.1007/s00464-023-09937-4) 21
Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery 20
Survival benefit of second line therapies for recurrent hepatocellular carcinoma: repeated hepatectomy, thermoablation and second-line transplant referral in a real life national scenario 5
Totale 5.687
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.645
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.645
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.217 0 0 0 94 143 191 190 197 192 89 37 84
2020/2021828 137 81 27 28 16 38 21 49 50 35 46 300
2021/20221.005 105 43 58 76 88 52 19 68 29 43 256 168
2022/20231.220 110 198 64 167 59 103 31 89 223 24 99 53
2023/2024308 25 58 15 34 32 54 20 20 6 14 16 14
2024/2025380 48 182 91 59 0 0 0 0 0 0 0 0
Totale 5.687